FIELD OF THE INVENTION
The present invention relates to the use of C-reactive protein (CRP) in combination with spleen cells and/or peripheral blood cells (monocytes/macrophages and/or dendritic cells) to produce suppressive macrophages and/or dendritic cells for the treatment of systemic lupus